Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06931158 · ClinicalTrials.gov registry record · NA

HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain

A NA study of Chronic Pain and Chronic Low Back Pain, sponsored by Rhode Island Hospital.

Recruiting
Registry status
NA
Development phase
340
Enrollment target
1
Study location

NCT06931158: Recruiting NA study of Chronic Pain and Chronic Low Back Pain, sponsored by Rhode Island Hospital.

NCT06931158 is a NA study of Chronic Pain and Chronic Low Back Pain that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 340 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06931158, a NA study of Chronic Pain and Chronic Low Back Pain, is actively recruiting participants, sponsored by Rhode Island Hospital.

RECRUITING
Registry status
NA
Development phase
340 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to examine the effect of rationale condition when taking open-label placebos on pain by 1) comparing each rationale to the no rationale control condition and the no treatment control condition; and 2) comparing the rationale conditions to each other. We also aim to examine the effect of rationale condition on prescription opioid use by 1) comparing each rationale to the no rationale control condition and the no treatment control condition; and 2) comparing the rationale conditions to each other. This study will include patients with chronic low back pain. The main question it aims to answer is: How do rationales influence the effects of open-label placebos? Researchers will compare different rationales given when taking an open-label placebo and a no-treatment group and a no rationale group taking OLPs.

Primary Outcome

Single-item assessing current pain level from 0 (min value) to 10 (max value). Higher scores indicate more pain intensity

Interventions

  • BEHAVIORAL Mindfulness
  • DRUG Open-label Placebo
  • BEHAVIORAL Standard Rationale
  • BEHAVIORAL Control Rationale

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 2025-03-01
Est. Completion 2027-03
Phase NA
Rhode Island Hospital

130 total trials

What NCT06931158 shows while recruiting

NCT06931158 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (56% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 4 interventions - of which Mindfulness is the first listed.

NCT06931158 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06931158 about?

NCT06931158 is a clinical study titled "HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain". The goal of this clinical trial is to examine the effect of rationale condition when taking open-label placebos on pain by 1) comparing each rationale to the no rationale control condition and the no treatment control condition; and 2) comparing the rationale conditions to each other. We also aim to...

What is the current status of trial NCT06931158?

This trial is currently recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2025-03-01. Estimated completion is 2027-03.

What conditions does trial NCT06931158 study?

This clinical trial studies the following conditions: Chronic Pain, Chronic Low Back Pain.

What interventions are being tested in trial NCT06931158?

The interventions under investigation include: Mindfulness (BEHAVIORAL), Open-label Placebo (DRUG), Standard Rationale (BEHAVIORAL), Control Rationale (BEHAVIORAL).

Who is sponsoring clinical trial NCT06931158?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06931158 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06931158's enrollment target sits among peer trials

340 44th of 301 higher than 258 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

  • NCT04545424 · 340 participants · Phase 2

    Trial of Therapeutic Hypothermia in Patients With ARDS

  • NCT04806958 · 340 participants · NA

    The PulsePoint Study

  • NCT05323409 · 340 participants · NA

    Improving Comprehensive Care of Cancer Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06931158, the US trial registry maintained by the National Library of Medicine. NCT06931158 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.